当前位置:首页 - 行情中心 - 新华医疗(600587) - 财务分析 - 现金流量表

新华医疗

(600587)

  

流通市值:78.99亿  总市值:78.99亿
流通股本:6.07亿   总股本:6.07亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,656,606,981.772,104,694,559.449,219,926,033.96,543,184,025.82
  收到的税费返还3,982,057.363,226,715.9812,764,005.932,761,465.63
  收到其他与经营活动有关的现金147,937,696.11138,562,696.79256,022,825.72217,994,965.2
  经营活动现金流入小计4,808,526,735.242,246,483,972.219,488,712,865.556,763,940,456.65
  购买商品、接受劳务支付的现金2,956,737,843.891,245,554,948.575,790,923,266.024,258,430,728.82
  支付给职工以及为职工支付的现金885,644,034.85511,183,997.341,706,551,621.451,280,425,889.34
  支付的各项税费269,029,146.45140,936,880.86418,591,288.93344,602,000.05
  支付其他与经营活动有关的现金432,384,077.33281,145,586.89872,009,768.75660,818,055.62
  经营活动现金流出小计4,543,795,102.522,178,821,413.668,788,075,945.156,544,276,673.83
  经营活动产生的现金流量净额264,731,632.7267,662,558.55700,636,920.4219,663,782.82
二、投资活动产生的现金流量:
  收回投资收到的现金4,240,041.872,324,724.0228,705,032.4612,405,032.46
  取得投资收益收到的现金5,549,102.25-89,336,819.736,547,734.08
  处置固定资产、无形资产和其他长期资产收回的现金净额6,7304,6301,035,945.751,020,035.75
  处置子公司及其他营业单位收到的现金净额--103,563,260.5199,870,479.75
  投资活动现金流入小计9,795,874.122,329,354.02222,641,058.45119,843,282.04
  购建固定资产、无形资产和其他长期资产支付的现金35,160,031.6218,830,367.55381,549,258.53298,226,154.22
  投资支付的现金9,800,000-23,944,877.4223,944,877.42
  支付其他与投资活动有关的现金708,500,000708,000,000--
  投资活动现金流出小计753,460,031.62726,830,367.55405,494,135.95322,171,031.64
  投资活动产生的现金流量净额-743,664,157.5-724,501,013.53-182,853,077.5-202,327,749.6
三、筹资活动产生的现金流量:
  取得借款收到的现金423,773,740.22301,000,0001,194,730,000935,150,000
  收到其他与筹资活动有关的现金--22,809,962.7111,000,000
  筹资活动现金流入小计423,773,740.22301,000,0001,217,539,962.71946,150,000
  偿还债务支付的现金541,813,203.26323,283,990.521,149,833,684.23893,137,723.08
  分配股利、利润或偿付利息支付的现金83,694,859.7413,582,153.7352,942,702.7198,794,969.21
  其中:子公司支付给少数股东的股利、利润5,542,8364,742,83610,324,0007,484,000
  支付其他与筹资活动有关的现金10,967,286.935,207,847.4935,082,06424,141,009.22
  筹资活动现金流出小计636,475,349.93342,073,991.711,537,858,450.931,116,073,701.51
  筹资活动产生的现金流量净额-212,701,609.71-41,073,991.71-320,318,488.22-169,923,701.51
四、汇率变动对现金及现金等价物的影响-5,647,558.24-3,483,751.12-371,650.4337,491.42
五、现金及现金等价物净增加额-697,281,692.73-701,396,197.81197,093,704.25-152,550,176.87
  加:期初现金及现金等价物余额2,966,856,645.272,966,856,645.272,769,762,941.022,769,762,941.02
  期末现金及现金等价物余额2,269,574,952.542,265,460,447.462,966,856,645.272,617,212,764.15
补充资料:
  净利润289,313,008.85-528,134,579.86-
  资产减值准备38,747,565.63-78,503,721.65-
  固定资产和投资性房地产折旧98,166,703.01-192,071,005.02-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧98,166,703.01-192,071,005.02-
  无形资产摊销8,446,728.04-20,694,272.32-
  长期待摊费用摊销19,543,711.77-41,487,228.34-
  处置固定资产、无形资产和其他长期资产的损失-187,412.37-993,363.98-
  固定资产报废损失232,381.18-1,755,394.88-
  财务费用1,380,669.63-41,777,624.07-
  投资损失24,410,239.63--39,100,637.21-
  递延所得税2,959,163.84--6,891,990.48-
  其中:递延所得税资产减少670,749.42--9,541,473.83-
    递延所得税负债增加2,288,414.42-2,649,483.35-
  存货的减少250,749,656.56-398,244,280.46-
  经营性应收项目的减少-497,046,212.49-16,374,680.42-
  经营性应付项目的增加-15,221,309.08--639,184,402.26-
  现金的期末余额2,269,574,952.54-2,966,856,645.27-
  减:现金的期初余额2,966,856,645.27-2,769,762,941.02-
  现金及现金等价物的净增加额-697,281,692.73-197,093,704.25-
公告日期2026-08-292026-04-302026-04-302025-10-31
审计意见(境内)标准无保留意见
TOP↑